DashboardPortfoliosWatchlistCommunityDiscoverScreener
  • Community
  • /
  • Japan
  • /
  • Consumer Retailing
Author Program NEWCreate Narrative
3349 logo

COSMOS Pharmaceutical Corporation Stock Price

TSE:3349 Community·JP¥510.1b Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 2 Fair Values set on narratives written by author
Author Program NEWCreate Narrative

3349 Share Price Performance

JP¥6,436.00
-2204.00 (-25.51%)
​
JP¥6,436.00
-2204.00 (-25.51%)
​
Price JP¥6,436.00
Sun, 20 Sep 26
Share Pricen/a

3349 Community Narratives

There are no narratives available yet.
Create Narrative
There are no community narratives available.

Trending Discussion

No trending discussion available.

Recently Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Adequate balance sheet with acceptable track record.

0 Risks
2 Rewards
View Full Analysis

COSMOS Pharmaceutical Corporation Key Details

JP¥1.1t

Revenue

JP¥869.9b

Cost of Revenue

JP¥229.7b

Gross Profit

JP¥197.6b

Other Expenses

JP¥32.0b

Earnings

Last Reported Earnings
May 31, 2026
Next Reporting Earnings
n/a
404.33
20.89%
2.91%
24.9%
View Full Analysis

About 3349

Founded
1983
Employees
5984
CEO
Hideaki Yokoyama
WebsiteView website
www.cosmospc.co.jp

COSMOS Pharmaceutical Corporation engages in the retail sale of pharmaceuticals, cosmetics, daily necessities, and food products in Japan. The company offers general medicines, energy drinks, oral and nursing care products, vitamins, health foods, diet foods, and prescriptions; and hair care and bath products. It also provides baby products, detergents, insect repellents, air fresheners, bath and toilet products, cooking supplies, gardening supplies, household and cleaning supplies, and clothing; processed foods, daily necessities, seasonings, confectionery, beverages, and alcohol; and tobacco and other products. In addition, the company engages in the maintenance and management of buildings and commercial facilities, traffic control, and security contracting activities. It sells its products through retail stores and online. COSMOS Pharmaceutical Corporation was incorporated in 1983 and is headquartered in Fukuoka City, Japan.

Recent 3349 News & Updates

Analysis Article • Jul 15

Analysts Have Been Trimming Their COSMOS Pharmaceutical Corporation (TSE:3349) Price Target After Its Latest Report

Shareholders might have noticed that COSMOS Pharmaceutical Corporation ( TSE:3349 ) filed its annual result this time...

Recent updates

No updates

COSMOS Pharmaceutical Corporation Competitors

3382 logo

Seven & i Holdings

Symbol: TSE:3382
Market cap: JP¥4.3t
8267 logo

Aeon

Symbol: TSE:8267
Market cap: JP¥3.6t
View more competitors

Make Better Investing Decisions Anywhere

Scan to download
Open AppStoreOpen Google Play
Chrome Web Store
Level 5, 320 Pitt Street, Sydney
Financial Data provided by S&P Global Market Intelligence LLC, analysis provided by Simply Wall Street Pty Ltd. Copyright © 2026, S&P Global Market Intelligence LLC. All rights reserved.
View Data Sources
Markets
  • US: NYSE & NASDAQ
  • UK: FTSE
  • Australia: ASX
  • India: NIFTY
  • Canada: TSX
  • South Africa: JSE
  • Japan: NIKKEI
  • South Korea: KOSPI
  • Germany: DAX
Investing Ideas
  • Undervalued Companies
  • Dividend Powerhouses
  • Insider Buying
  • Nuclear Energy
  • Autonomous Vehicles
  • Artificial Intelligence
  • Crypto and Blockchain
  • Cybersecurity
  • More ideas
Stock Communities
  • AstraZeneca
  • HSBC Holdings
  • Shell
  • Unilever
  • Diageo
  • Rio Tinto Group
  • RELX
  • BP
  • Barclays
Features & Tools
  • Portfolio Tracker
  • Stock Screener & Alerts
  • Narratives & Fair Values
  • Dividend Calculator
News & Discovery
  • Latest Stock News
  • Global Market Insights
  • The Foxhole
  • Investing Ideas
  • Community Narratives
  • What's New
Simply Wall St
  • Plans & Pricing
  • Advertising
  • About Us
  • Contact Us
  • Careers
  • Help Center
  • Learn Stock Investing
  • Affiliate Program
  • Business & Enterprise
  • Charlie AI
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.
© 2026 Simply Wall Street Pty Ltd, US Design Patent #29/544/281, Community and European Design Registration #2845206
  • Terms and Conditions
  • Privacy Policy
  • AI Terms
  • Financial Services Guide